Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jong-Mu Sun

Showing results (151-160 of 303) with videos related to

Pageof 31
Sort By:
International Journal of Cancer|March 13, 2026
Treatment patterns and clinical outcomes in real-world patients with small-cell lung cancer in South Korea: A single-center experienceSehhoon Park, Danbee Kang, Jin Lee, et al.
Frontiers in Oncology|November 7, 2024
Clinical utility of circulating tumor DNA profiling in detecting targetable fusions in non-small cell lung cancerYoung-Gon Kim, Boram Lee, Changhee Ha, et al.
World Neurosurgery|August 28, 2016
Outcomes of Gamma Knife Radiosurgery in Combination with Crizotinib for Patients with Brain Metastasis from Non-Small Cell Lung CancerJung Won Choi, Doo-Sik Kong, Ho Jun Seol, et al.
The Korean Journal of Internal Medicine|June 20, 2018
Efficacy and safety of cisplatin and weekly docetaxel in patients with recurrent or metastatic squamous cell carcinoma of the head and neckMoon Jin Kim, Sung Min Kim, Hyun Ae Jung, et al.
Cancer Research and Treatment|February 18, 2015
Definitive Bimodality Concurrent Chemoradiotherapy in Patients with Inoperable N2-positive Stage IIIA Non-small Cell Lung CancerJae Myoung Noh, Yong Chan Ahn, Hyebin Lee, et al.
Cancer|November 2, 2004
A combination of HER-2 status and the St. Gallen classification provides useful information on prognosis in lymph node-negative breast carcinomaJong-Mu Sun, Wonshik Han, Seock-Ah Im, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 22, 2019
Diagnostic value of surveillance <sup>18</sup>F-fluorodeoxyglucose PET/CT for detecting recurrent esophageal carcinoma after curative treatmentSoo Jeong Kim, Seung Hyup Hyun, Seung Hwan Moon, et al.
Lung Cancer (Amsterdam, Netherlands)|October 30, 2012
Favorable clinical outcomes of pemetrexed treatment in anaplastic lymphoma kinase positive non-small-cell lung cancerHa Yeon Lee, Hee Kyung Ahn, Ji Yun Jeong, et al.
Lung Cancer (Amsterdam, Netherlands)|June 21, 2011
Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapySeung Tae Kim, Ji Eun Uhm, Jeeyun Lee, et al.
Cancer|April 7, 2021
High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy ProgramSehhoon Park, Steve Olsen, Bo Mi Ku, et al.
Pageof 31

Showing results (151-160 of 303) with videos related to

Sort By:
Pageof 31
International Journal of Cancer|March 13, 2026
Treatment patterns and clinical outcomes in real-world patients with small-cell lung cancer in South Korea: A single-center experienceSehhoon Park, Danbee Kang, Jin Lee, et al.
Frontiers in Oncology|November 7, 2024
Clinical utility of circulating tumor DNA profiling in detecting targetable fusions in non-small cell lung cancerYoung-Gon Kim, Boram Lee, Changhee Ha, et al.
World Neurosurgery|August 28, 2016
Outcomes of Gamma Knife Radiosurgery in Combination with Crizotinib for Patients with Brain Metastasis from Non-Small Cell Lung CancerJung Won Choi, Doo-Sik Kong, Ho Jun Seol, et al.
The Korean Journal of Internal Medicine|June 20, 2018
Efficacy and safety of cisplatin and weekly docetaxel in patients with recurrent or metastatic squamous cell carcinoma of the head and neckMoon Jin Kim, Sung Min Kim, Hyun Ae Jung, et al.
Cancer Research and Treatment|February 18, 2015
Definitive Bimodality Concurrent Chemoradiotherapy in Patients with Inoperable N2-positive Stage IIIA Non-small Cell Lung CancerJae Myoung Noh, Yong Chan Ahn, Hyebin Lee, et al.
Cancer|November 2, 2004
A combination of HER-2 status and the St. Gallen classification provides useful information on prognosis in lymph node-negative breast carcinomaJong-Mu Sun, Wonshik Han, Seock-Ah Im, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 22, 2019
Diagnostic value of surveillance <sup>18</sup>F-fluorodeoxyglucose PET/CT for detecting recurrent esophageal carcinoma after curative treatmentSoo Jeong Kim, Seung Hyup Hyun, Seung Hwan Moon, et al.
Lung Cancer (Amsterdam, Netherlands)|October 30, 2012
Favorable clinical outcomes of pemetrexed treatment in anaplastic lymphoma kinase positive non-small-cell lung cancerHa Yeon Lee, Hee Kyung Ahn, Ji Yun Jeong, et al.
Lung Cancer (Amsterdam, Netherlands)|June 21, 2011
Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapySeung Tae Kim, Ji Eun Uhm, Jeeyun Lee, et al.
Cancer|April 7, 2021
High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy ProgramSehhoon Park, Steve Olsen, Bo Mi Ku, et al.
Pageof 31